Skip to main content
. 2022 Feb 7;269(7):3690–3699. doi: 10.1007/s00415-022-10992-5

Table 1.

Cardiovascular characteristics and comedication of SBMA patients and controls

SBMA patients (N = 30) Controls (N = 11)
Age (years), mean ± SD 55.7 ± 11.9 41.3 ± 14.0
Arterial hypertension (AHT) n, (%) 14 (46.7) 2 (18.2)
Diabetes, n (%) 5 (16.7) 0
ACE inhibitor or angiotensin-1 receptor antagonist, n 7
Beta-blocker, n 7
Other antihypertensive medication, n 6

ACE angiotensin converting enzyme, SBMA spinobulbar muscular atrophy